You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Advanced solid tumor

Showing 9951 - 9975 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Rare Cancers, Multiomics Trial in Heidelberg

Recruiting
  • Rare Cancers
  • Multiomics
    • Heidelberg, Germany
      German Cancer Research Center
    May 2, 2023

    Hepatocellular Carcinoma, Circulating Tumor Cell, Whole Genome Sequencing Trial in Chongqing

    Recruiting
    • Hepatocellular Carcinoma
    • +2 more
      • Chongqing, China
        the second affiliated hospital of Chongqing Medical University
      Feb 7, 2022

      Cirrhosis Trial in Rochester (ACE (AI-Cirrhosis-ECG) 2.0)

      Not yet recruiting
      • Cirrhosis
      • ACE (AI-Cirrhosis-ECG) 2.0
      • Rochester, Minnesota
        Mayo Clinic Minnesota
      Mar 12, 2023

      Polycythemia Vera Trial (Hydroxyurea)

      Not yet recruiting
      • Polycythemia Vera
      • (no location specified)
      May 2, 2023

      Liver Tumors Trial in Beijing (Tislelizumab plus tyrosine kinase inhibitor)

      Recruiting
      • Liver Neoplasms
      • Tislelizumab plus tyrosine kinase inhibitor
      • Beijing, Beijing, China
        302 Hospital
      Sep 22, 2023

      Malignant Tumors Trial in Guangzhou (LM101, Toripalimab, Rituximab)

      Recruiting
      • Malignant Tumors
      • Guangzhou, Guangdong, China
        Sun Yat-sen University Cancer Center
      Jan 17, 2023

      Neuroendocrine Tumors, NET, Pancreatic Neuroendocrine Tumor Trial in Newport Beach, Denver, Dallas (nab-sirolimus)

      Not yet recruiting
      • Neuroendocrine Tumors
      • +4 more
      • Newport Beach, California
      • +2 more
      Aug 16, 2023

      Lung Cancer Trial (Microwave ablation)

      Unknown status
      • Lung Cancer
      • Microwave ablation
      • (no location specified)
      Jun 23, 2020

      Anaplastic Astrocytoma, IDH-Wildtype, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma Trial in Houston (other,

      Recruiting
      • Anaplastic Astrocytoma, IDH-Wildtype
      • +8 more
      • Quality-of-Life Assessment
      • +3 more
      • Houston, Texas
        M D Anderson Cancer Center
      Dec 8, 2022

      A Real-world Study of Inetetamab for First-line Treatment of MBC

      Not yet recruiting
      • Breast Cancer
      • Real-world Study
      • (no location specified)
      Aug 6, 2023

      AML, Adult Recurrent, MDS Trial in United States (LYT-200)

      Recruiting
      • AML, Adult Recurrent
      • MDS
      • Los Angeles, California
      • +13 more
      Apr 12, 2023

      Biomarkers for Clinical Hypoxia Evaluation in Cervical Cancer

      Recruiting
      • Cervical Cancer
      • Biopsy of tumour
      • MRI scans
      • Manchester, Greater Manchester, United Kingdom
        The Christie NHS Foundation Trust
      Aug 25, 2021

      Colorectal Tumors, Colorectal Adenoma, Colorectal Cancer Trial in Shatin, Hong Kong (SMT04 formula, Active )

      Recruiting
      • Colorectal Neoplasms
      • +2 more
      • SMT04 formula
      • Active placebo
      • Shatin, New Territories, Hong Kong
      • +1 more
      Dec 28, 2022

      VectOr ChAnge defibriLlatIon in Refractory Shockable rhyThms

      Recruiting
      • Cardiac Arrest
      • +2 more
      • Enhanced cardiac arrest bundle
      • Oxford, Oxfordshire, United Kingdom
        Thames Valley Air Ambulance
      Jun 21, 2023

      Breast Tumors Trial in Roma, Rome (Single-cell RNA sequencing (scRNAseq), whole-exome sequencing (WES))

      Recruiting
      • Breast Neoplasms
      • Single-cell RNA sequencing (scRNAseq), whole-exome sequencing (WES)
      • Roma, Italy
      • +1 more
      Mar 29, 2023

      Glioblastoma Trial in San Francisco (Cannabidiol (CBD), Placebo)

      Not yet recruiting
      • Glioblastoma
      • Cannabidiol (CBD)
      • Placebo
      • San Francisco, California
        University of California San Francisco Brain Tumor Center
      Feb 21, 2023

      Neuroblastoma Trial in Houston (GINAKIT Cells, Cyclophosphamide, Fludarabine)

      Active, not recruiting
      • Neuroblastoma
      • GINAKIT Cells
      • +2 more
      • Houston, Texas
        Texas Children's Hospital
      Jan 18, 2023

      Ulcerative Colitis Trial in Worldwide (Adalimumab, Adalimumab Placebo, Etrolizumab)

      Completed
      Has Results
      • Ulcerative Colitis
      • Lakewood, Colorado
      • +87 more
      Jul 21, 2021

      Metastatic Castration-resistant Prostate Cancer (mCRPC) Trial (225Ac-PSMA-R2, 68Ga-PSMA-R2)

      Not yet recruiting
      • Metastatic Castration-resistant Prostate Cancer (mCRPC)
      • (no location specified)
      Aug 8, 2023

      Oropharynx Cancer, Oropharynx Tumor, Tonsil Cancer Trial in Copenhagen (Transoral ultrasound, Transcervical ultrasound)

      Completed
      • Oropharynx Cancer
      • +7 more
      • Transoral ultrasound
      • Transcervical ultrasound
      • Copenhagen, Denmark
        Department of Otorhinolaryngology, Head & Neck Surgery & Audiolo
      Jan 30, 2023

      Healthy Trial in Secaucus (HF1K16, Placebo)

      Terminated
      • Healthy
      • Secaucus, New Jersey
        Frontage Clinical Services, Inc.
      May 18, 2022

      HR+/HER2- Advanced Breast Cancer Trial in Beijing (Dalpiciclib, Chidamide)

      Not yet recruiting
      • HR+/HER2- Advanced Breast Cancer
      • Beijing, Beijing, China
        The Fifth Medical Center of PLA General Hospital
      Oct 17, 2022

      Therapeutic Response Evaluation by CTC Expansion System

      Enrolling by invitation
      • Circulating Tumor Cells
        • Taipei, Taiwan
          Taipei Medical University Hospital
        Jul 12, 2021

        Unresectable Melanoma, Metastatic Melanoma, Stage III NSCLC Trial in Louisville, New York (IOV-4001)

        Recruiting
        • Unresectable Melanoma
        • +3 more
        • IOV-4001
        • Louisville, Kentucky
        • +2 more
        Nov 21, 2022

        NSCLC Trial in China (BBP-398, osimertinib)

        Recruiting
        • NSCLC
        • Beijing, Beijing, China
        • +4 more
        Sep 4, 2023